Pharmacogenomic testing can identify how genetic variations affect drug responses, and help guide treatment strategies for patients suffering from chronic pain.
Bryant Furlow
Contributing Writer https://www.clinicalpainadvisor.com
Bryant Furlow is a contract medical journalist for the Haymarket Medical Network. He holds a BS in biology (summa cum laude) from the University of New Mexico. He covers radiation oncology, immunotherapy, tumor biology, clinical research and health care policy. Prior to joining Haymarket in 2010, Bryant was a newspaper reporter in New Mexico, where he won awards for public health and investigative journalism. He also reports for The Lancet Oncology news desk.
